Target intelligence / Profile preview

Beclin 1 pseudogene 2 (BECN1P2)

Target: BECN1P2
Molecular classification: Other, Pseudogene — not a protein-coding gene

Overview

Beclin 1 pseudogene 2 (BECN1P2) is classified as a pseudogene in the human genome and does not encode a functional protein. Pseudogenes are typically remnants of protein-coding genes that have lost their protein-coding potential due to mutations, insertions, or deletions. While the closely related gene Beclin 1 (BECN1) encodes a critical regulator of autophagy and is implicated in various cellular processes and disease states, BECN1P2 itself lacks any established biological, therapeutic, or diagnostic function and is not considered a drug target[2].

Other names: Beclin 1 pseudogene 2BECN1P2

Beyond the preview

Go deeper on Beclin 1 pseudogene 2 (BECN1P2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Beclin 1 pseudogene 2 (BECN1P2).

Explore the full profile